Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Fusion Antibodies Plc ( (GB:FAB) ) is now available.
Fusion Antibodies plc announced that its issued share capital consists of 113,656,253 ordinary shares, each with one voting right. This information is crucial for shareholders to determine their interests in the company under the FCA’s Disclosure Guidance and Transparency Rules. The announcement reflects the company’s transparency and regulatory compliance, which may impact shareholder engagement and confidence.
Spark’s Take on GB:FAB Stock
According to Spark, TipRanks’ AI Analyst, GB:FAB is a Neutral.
Fusion Antibodies Plc faces substantial financial hurdles with declining revenues and significant losses. Technical analysis indicates bearish momentum, and valuation metrics highlight unprofitability. Despite these challenges, recent corporate events, including successful fundraising and strategic collaborations, offer some optimism for future growth. However, the immediate financial health remains a primary concern, resulting in a low overall stock score.
To see Spark’s full report on GB:FAB stock, click here.
More about Fusion Antibodies Plc
Fusion Antibodies plc is a Belfast-based contract research organisation specializing in pre-clinical antibody discovery, engineering, and supply for therapeutic drug and diagnostic applications. Established in 2001 as a spin-out from Queen’s University Belfast, the company offers a range of services including antibody generation, development, production, characterization, and optimization. Fusion Antibodies has a strong international client base, including eight of the top 10 global pharmaceutical companies by revenue, and is committed to advancing pharmaceutical and diagnostic innovations efficiently.
Average Trading Volume: 811,341
Technical Sentiment Signal: Sell
Current Market Cap: £6.93M
Learn more about FAB stock on TipRanks’ Stock Analysis page.